Tundra Space

Tundra Space

Clinical Research Directory

Browse clinical research sites, groups, and studies.

Back to Studies
NOT YET RECRUITING
NCT07777133
PHASE1

A Study to Evaluate the Metabolism, the Routes and Extent of Elimination, and Drug Levels of [14C]Navlimetostat (BMS-986504) in Healthy Female Participants

Sponsor: Bristol-Myers Squibb

View on ClinicalTrials.gov

Summary

The purpose of this study is to evaluate the metabolism, the routes and extent of elimination, and drug levels of \[14C\]Navlimetostat (BMS-986504) in healthy female participants

Official title: A Phase 1 Study to Evaluate the Mass Balance, Metabolism, Excretion, and Pharmacokinetics of [14C]Navlimetostat (BMS-986504) at Steady State in Healthy Female Participants

Key Details

Gender

FEMALE

Age Range

18 Years - 55 Years

Study Type

INTERVENTIONAL

Enrollment

6

Start Date

2026-09-16

Completion Date

2026-12-05

Last Updated

2026-08-20

Healthy Volunteers

Yes

Interventions

DRUG

Navlimetostat

Specified dose on specified days

DRUG

[14C]Navlimetostat

Specified dose on specified days

Locations (2)

Local Institution - 0001

Madison, Wisconsin, United States

Local Institution - 0002

Groningen, Provincie Groningen, Netherlands